Package 72162-2436-1
Brand: chlordiazepoxide hcl and clidinium bromide
Generic: chlordiazepoxide hcl and clidinium bromidePackage Facts
Identity
Package NDC
72162-2436-1
Digits Only
7216224361
Product NDC
72162-2436
Description
100 CAPSULE in 1 BOTTLE (72162-2436-1)
Marketing
Marketing Status
Brand
chlordiazepoxide hcl and clidinium bromide
Generic
chlordiazepoxide hcl and clidinium bromide
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bf5abb7c-5ad5-4817-8d72-0b1ae5a52741", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["ec7733c5-3aad-496a-8007-5d7596ede630"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (72162-2436-1)", "package_ndc": "72162-2436-1", "marketing_start_date": "20250213"}], "brand_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "product_id": "72162-2436_bf5abb7c-5ad5-4817-8d72-0b1ae5a52741", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "72162-2436", "dea_schedule": "CIV", "generic_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA215835", "marketing_category": "ANDA", "marketing_start_date": "20221001", "listing_expiration_date": "20261231"}